Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
32.41
+4.20 (14.89%)
May 20, 2026, 4:00 PM EDT - Market closed
Roivant Sciences Employees
Roivant Sciences had 750 employees as of March 31, 2025. The number of employees decreased by 158 or -17.40% compared to the previous year.
Employees
750
Change (1Y)
-158
Growth (1Y)
-17.40%
Revenue / Employee
$11,013
Profits / Employee
-$399,695
Market Cap
23.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 750 | -158 | -17.40% |
| Mar 31, 2024 | 908 | 4 | 0.44% |
| Mar 31, 2023 | 904 | 41 | 4.75% |
| Mar 31, 2022 | 863 | 198 | 29.77% |
| Jun 30, 2021 | 665 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Genmab | 3,088 |
| Jazz Pharmaceuticals | 2,890 |
| Incyte | 2,844 |
| Insmed | 1,664 |
| Ascendis Pharma | 1,189 |
ROIV News
- 16 hours ago - Roivant Sciences rises 15.2% - TheFly
- 16 hours ago - 2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug - Barrons
- 17 hours ago - Roivant Sciences rises 11.7% - TheFly
- 17 hours ago - Roivant Sciences Q4 Earnings Call Highlights - MarketBeat
- 20 hours ago - Roivant Sciences Earnings Call Transcript: Q4 2026 - Transcripts
- 20 hours ago - Roivant Sciences Earnings release: Q4 2026 - Filings
- 20 hours ago - Roivant Sciences Annual report: Q4 2026 - Filings
- 20 hours ago - Roivant Sciences Slides: Q4 2026 - Filings